Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
81.26
+2.00 (2.52%)
At close: Oct 15, 2025, 4:00 PM EDT
83.39
+2.13 (2.62%)
After-hours: Oct 15, 2025, 6:30 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.67 billion as of October 15, 2025. Its market cap has increased by 87.07% in one year.
Market Cap
2.67B
Enterprise Value
2.46B
1-Year Change
87.07%
Ranking
Category
Stock Price
$81.26
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.67B, an increase of 1,743.89%. That is a compound annual growth rate of 132.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 2.60B | 33.56% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |